We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ENOV market cap is 2.44B. The company's latest EPS is USD -0.6090 and P/E is -73.25.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 406.15M | 428.5M | 417.52M | 455.02M | 516.27M |
| Operating Income | -24.97M | -14.49M | -20.49M | -8.46M | -35.01M |
| Net Income | -23.35M | -10M | -2.88M | 2.96M | -72M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.33B | 3.07B | 3.85B | 1.6B | 1.71B |
| Operating Income | 207.81M | 165.79M | 256.42M | -71.78M | -68.41M |
| Net Income | -527.65M | 42.63M | 72.14M | -13.29M | -33.26M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 4.3B | 4.44B | 4.4B | 4.51B | 5.48B |
| Total Liabilities | 854.32M | 992.79M | 959.19M | 1.09B | 2.17B |
| Total Equity | 3.45B | 3.45B | 3.44B | 3.42B | 3.31B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 7.39B | 7.35B | 8.52B | 4.27B | 4.51B |
| Total Liabilities | 3.9B | 3.76B | 3.85B | 823.45M | 1.09B |
| Total Equity | 3.49B | 3.59B | 4.66B | 3.45B | 3.42B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 7.46M | 35.56M | 66.57M | 134.99M | -36.16M |
| Investing | -34.39M | -165.99M | -183.1M | -242.47M | -797.84M |
| Financing | 24.5M | 138.71M | 125.01M | 127.8M | 864.54M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 130.95M | 301.94M | 356.1M | -55.86M | 134.99M |
| Investing | -1.63B | -175.08M | -320.48M | -176.39M | -242.47M |
| Financing | 1.37B | -131.65M | 584.91M | -465.13M | 127.8M |
| Market Cap | 2.44B |
| Price to Earnings Ratio | -73.25 |
| Price to Sales Ratio | 1.43 |
| Price to Cash Ratio | 67.33 |
| Price to Book Ratio | 0.71 |
| Dividend Yield | - |
| Shares Outstanding | 54.62M |
| Average Volume (1 week) | 722.93k |
| Average Volume (1 Month) | 599.59k |
| 52 Week Change | -25.72% |
| 52 Week High | 66.14 |
| 52 Week Low | 43.04 |
| Spread (Intraday) | 21 (39.62%) |
| Company Name | Enovis Corporation |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.enovis.com |
| Industry | ortho,prosth,surg appl,suply (3842) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
